Pfizer Inc.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin f…
Drug Manufacturers - General
US, New York [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared Pfizer Inc. (PFE) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.
| Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Drug Manufacturers—General Average | - - | - - | - - | 56,129.87 | 6,136.00 | 851.07 | 3,761.58 | 108.83 | 0.01 | 15.7770 | 0.68 | 0.5613 | 0.0000 | 0.00 | 0.08 | 0.9126 | - - | ||
| Maximum | - - | - - | - - | 198,097.00 | 13,765.00 | 2,179.00 | 18,021.00 | 1,294.00 | 0.04 | 46.2856 | 2.71 | 0.7672 | 0.2203 | 0.03 | 0.53 | 3.5022 | - - | ||
| Minimum | - - | - - | - - | 0.00 | 91.00 | -82.00 | -1,283.00 | -2,626.00 | 0.00 | -9.7211 | -0.15 | 0.0683 | -0.9021 | -0.08 | -0.04 | 0.0000 | - - | ||
| AbbVie Inc. ABBV | 166.00 | -0.28 -0.17% | 1,914 vs. 5,369 | 293,345.00 | 12,310.00 | 1,369.00 | 3,847.00 | -2,384.00 | 0.7700 | 58.3938 | 0.0087 | 0.6684 | 0.1112 | 0.1710 | 0.0092 | 0.7229 | 1,767.00 | ||
| Gilead Sciences, Inc. GILD | 88.27 | -0.19 -0.21% | 2,405 vs. 6,645 | 110,008.00 | 6,686.00 | -4,170.00 | 2,114.00 | 10,656.00 | -3.3400 | -5.4485 | 0.0109 | 0.7679 | -0.6237 | -0.2378 | -0.0741 | 0.8243 | 1,246.00 | ||
| Bristol-Myers Squibb Company BMY | 57.92 | 1.12 1.97% | 3,758 vs. 10,930 | 117,472.00 | 11,865.00 | -11,911.00 | 2,550.00 | 15,640.00 | -5.8900 | -2.2500 | 0.0113 | 0.7529 | -1.0039 | -0.7223 | -0.1203 | 0.9190 | 2,028.00 | ||
| Pfizer Inc. PFE | 25.05 | 0.19 0.74% | 16,720 vs. 35,518 | 141,929.00 | 14,879.00 | 3,115.00 | 387.00 | 121,318.00 | 0.5500 | 12.5852 | 0.0151 | 0.7056 | 0.2094 | 0.0338 | 0.0141 | 0.5659 | 5,666.00 | ||
| Amgen Inc. AMGN | 280.11 | 1.35 0.48% | 1,195 vs. 2,083 | 150,565.00 | 7,396.00 | -113.00 | 459.00 | -27,870.00 | -0.2100 | -335.6404 | 0.0080 | 0.5673 | -0.0153 | -0.0225 | -0.0012 | 0.8362 | 537.00 | ||
| Eli Lilly and Company LLY | 725.47 | -1.73 -0.24% | 3,001 vs. 3,342 | 688,700.00 | 8,768.00 | 2,242.00 | 179.00 | 12,553.00 | 2.4900 | 76.3636 | 0.0017 | 0.8250 | 0.2558 | 0.1751 | 0.0351 | 0.6775 | 949.00 | ||
| Merck & Co., Inc. MRK | 96.19 | -0.37 -0.38% | 4,177 vs. 9,512 | 243,326.00 | 15,809.00 | 4,762.00 | 2,229.00 | 56,697.00 | 1.8800 | 17.4190 | 0.0059 | 0.7511 | 0.3012 | 0.1180 | 0.0450 | 0.7284 | 2,529.00 | ||
| Johnson & Johnson JNJ | 152.35 | -2.42 -1.56% | 2,136 vs. 6,265 | 366,800.00 | 21,382.00 | 3,255.00 | 2,850.00 | 153,378.00 | 1.3500 | 29.1832 | 0.0076 | 0.6878 | 0.1522 | 0.0465 | 0.0189 | 0.8448 | 2,407.00 | ||
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.